Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

612
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
612
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

607
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
607
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

472
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
472
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

420
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
420
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

1.5K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.5K
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

285
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
285

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Normalization of nCounter Gene Expression Data Alters Molecular Diagnostics in Kidney Transplantation.

Journal of the American Society of Nephrology : JASN·2026
Same author

Detection of Kidney Allograft Rejection Using Urinary Chemokines.

Journal of the American Society of Nephrology : JASN·2025
Same author

Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure.

Journal of the American Society of Nephrology : JASN·2025
Same author

Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure.

Journal of the American Society of Nephrology : JASN·2024
Same author

Prognostic Biomarkers in Kidney Transplantation: A Systematic Review and Critical Appraisal.

Journal of the American Society of Nephrology : JASN·2023
Same author

Biologically derived epicardial patch induces macrophage mediated pathophysiologic repair in chronically infarcted swine hearts.

Communications biology·2023

Related Experiment Video

Updated: Mar 8, 2026

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

17.2K

From Humoral Theory to Performant Risk Stratification in Kidney Transplantation.

C Lefaucheur1, D Viglietti1, M Mangiola2

  • 1Paris Translational Research Center for Organ Transplantation, INSERM, UMR-S970, Paris, France; Kidney Transplant Department, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Journal of Immunology Research
|January 31, 2017
PubMed
Summary

Improving kidney transplant risk models requires analyzing donor-specific anti-HLA antibody (DSA) characteristics. Assessing DSA strength, complement binding, and IgG subclass enhances prediction of rejection and allograft failure.

More Related Videos

Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

17.5K
TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

5.5K

Related Experiment Videos

Last Updated: Mar 8, 2026

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

17.2K
Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

17.5K
TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

5.5K

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation Science

Background:

  • Donor-specific anti-HLA antibodies (DSA) are crucial for assessing kidney transplant rejection risk.
  • Current DSA detection methods lack sufficient accuracy for precise risk stratification.
  • Not all DSA possess equal pathogenicity, necessitating refined assessment.

Purpose of the Study:

  • To review advancements in modeling kidney transplant outcomes by incorporating detailed donor-specific anti-HLA antibody (DSA) characteristics.
  • To highlight the need for improved risk stratification beyond simple DSA detection.

Main Methods:

  • Review of recent advancements in assessing anti-HLA DSA properties.
  • Focus on DSA characteristics such as strength, complement-binding capacity, and IgG subclass composition.
  • Evaluation of enhanced risk stratification models for predicting allograft injury and failure.

Main Results:

  • Novel insights into DSA characteristics significantly improve risk stratification models.
  • Assessment of DSA strength, complement binding, and IgG subclass enhances prediction of allograft outcomes.
  • Current models based solely on DSA presence are insufficient for accurate risk stratification.

Conclusions:

  • Incorporating detailed DSA properties offers a promising approach to enhance kidney transplant risk stratification.
  • Further studies in large, unselected populations are needed to validate clinical benefits and cost-effectiveness.
  • Individualized treatment strategies can be facilitated by more accurate immunological risk assessment.